Ech9.0

Echinacea

Echinacea purpurea / angustifolia

The world's most popular immune herb, traditionally used to prevent and shorten colds and respiratory infections.

immunecold preventionimmune supportrespiratoryantiviral
Last reviewed: January 1, 2025
9.0/10
40+ studies
Evidence
high
Safety
300-500mg extract 3x daily at first symptoms, OR 2.5ml tincture 3x daily
Dose
- as needed
Time to Effect
Standardized extract (4% echinacosides or standardized alkylamides)
Best Form

Echinacea is a flowering plant native to North America that has become the best-selling herbal immune supplement globally. Research shows it can reduce the risk of catching colds and may shorten their duration. Different species (purpurea, angustifolia) and plant parts (root, aerial) have different active compounds. Most effective when started at first sign of symptoms.

Mechanisms of Action

⚡
Immune Stimulation

Activates immune cells to fight infection

🦠
Antiviral Activity

Direct action against respiratory viruses

Recommended Dose

300-500mg extract 3x daily at first symptoms, OR 2.5ml tincture 3x daily

300mg3000mg

Loading: High-dose at cold onset: 1000mg immediately, then 500mg every 2-3 hours for 24-48 hours

Optimal Timing

  • At first sign of symptoms
  • Multiple times daily during illness

Can be taken without food

Best Form

Standardized extract (4% echinacosides or standardized alkylamides)

Alternatives: Fresh plant tincture, Dried root/herb, Combined species products

E. purpurea aerial parts and E. angustifolia root have the most research. Fresh preparations may be more effective than dried.

Duration

Minimum: as needed

Optimal: as needed

Cycling: Best used acutely (at cold onset) or for 8 weeks max continuous use. Take breaks between courses.

Note: Most effective when started within 24 hours of symptom onset. Frequency matters more than single dose size.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🛡️
Cold Prevention

Reduced risk of catching colds

With continuous use
55% of users notice thispositive
⏱️
Shorter Illness

Reduced cold duration

When taken at onset
50% of users notice thispositive
High SafetyMax safe dose: Up to 3000mg/day for acute use
🟡
Autoimmune conditions

Use with caution; consult doctor

🟢
Pregnant/nursing

Short-term use likely safe; consult doctor

Who Should NOT Take This

  • Allergy to Asteraceae/daisy family plants
  • Autoimmune Conditions (contraindicated)
  • Ragweed Allergy - use with caution

Drug Interactions

Immunosuppressantsmoderate

May counteract immunosuppression

CYP450 substratesmild

May affect drug metabolism

cyclosporinecritical

Risk of organ rejection, treatment failure

tacrolimuscritical

Risk of organ rejection

prednisonemajor

Reduced steroid effectiveness, immune activation

adalimumabmajor

Reduced effectiveness, possible disease flare

Possible Side Effects

GI upsetuncommon

Tip: Take with food

Allergic reactionuncommon

Tip: Discontinue if rash or swelling occurs

Warnings

  • Start at first sign of symptoms for best effect
  • Not recommended for long-term continuous use
  • May cause allergic reaction in those allergic to ragweed/daisies

Top studies from 40+ peer-reviewed papers

meta-analysisn=1518
DOI

Pham TP et al. • Clinical nutrition ESPEN (2025)

“The meta-analysis of nine studies found that E. purpurea was effective in reducing the duration of treatment, the incidence of episodes, and antibiotic usage for URTI in children, with some positive effects on OM.”
Key Findings:
  • The meta-analysis found that E. purpurea significantly benefits URTI, reducing treatment duration (SMD = -0.19, 95 % CI [-0.30; -0.09], p < 0.01), incidence (RR = 0.81, 95 % CI [0.75; 0.87]), and antibiotic use (RR = 0.18, 95 % CI [0.13; 0.25], p < 0.01).
  • However, adverse events were moderately increased (RR = 1.38, 95 % CI [1.08; 1.78]), though generally mild.
  • For OM, E. purpurea lowered episode incidence (RR = 0.56, 95 % CI [0.44; 0.73], p < 0.01) but did not shorten treatment duration (p = 0.10).
systematic-reviewn=469
DOI

Weiner JD et al. • Lupus science & medicine (2025)

“We identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence.”
Key Findings:
  • We identified 227 herbal supplements with immunostimulatory properties, of which 15 were most strongly supported by the evidence.
  • This article may serve as a reference to help clinicians counsel patients with autoimmune skin diseases on the risks associated with use of specific herbal supplements.
  • Further research warranted to confirm findings
meta-analysisn=107
DOI

Deccy S et al. • Nutrients (2024)

“Echinacea supplementation did not influence erythropoietin, hemoglobin, hematocrit, or maximal oxygen uptake in athletes; however, the evidence base is limited.”
Key Findings:
  • There was also no statistically significant change in erythropoietin (effect size -0.29, p = 0.05, 95% CI -0.75-0.17, I2 = 67%) or maximal oxygen uptake (effect size -0.20, p = 0.95, 95% CI -0.60-0.21, I2 = 0%).
  • Six studies with a total of 107 athletes were included in the analysis.
  • Echinacea supplementation did not influence erythropoietin, hemoglobin, hematocrit, or maximal oxygen uptake in athletes; however, the evidence base is limited.
systematic-review
DOI

Crawford C et al. • Nutrients (2022)

“As we move toward a vision of health promotion and resilience rather than a sole focus on disease prevention and treatment, further work in this area of dietary supplements is of utmost importance.”
Key Findings:
  • Immune health products represent approximately 10% of all US dietary supplement sales.
  • The studies included eight of the 27 supplement ingredients identified through a market-driven scoping review.
  • Those ingredients used in single ingredient products were echinacea, elderberry, garlic, vitamin A, vitamin C, vitamin D, vitamin E, and zinc.
  • Whereas some studies may point to evidence for benefit, specific gaps preclude the authors from making firm statements with regard to the overall evidence-base for these products and ingredients and in answering the research questions.
meta-analysisn=10
DOI

Chan V et al. • Nutrients (2021)

“Overall, 12 of 183 ingredients contained in 199 products had evidence to support claims.”
Key Findings:
  • Meta-analysis (random effects model) indicated melatonin reduced self-reported jetlag following eastbound (n = 5) and westbound (n = 4) flights: standard mean difference -0.76 (95% CI = -1.06 to -0.45, I2 0%, p < 0.00001) and -0.66 (95% CI = -1.07 to -0.26, I2 45%, p = 0.001), respectively.
  • Pycnogenol also reduced edema scores (n = 3), standard mean -4.09 (95% CI = -6.44 to -1.74), I2 98%, p = 0.0006).
  • Of the 3842 studies identified, 23 met selection criteria: melatonin (n = 10), Pycnogenol (n = 4), various macronutrients (n = 2), caffeine (n = 2), Centella asiatica (n = 1), elderberry (n = 1), Echinacea (n = 1), fluid (n = 1), and Pinokinase (n = 1).
  • Overall, 12 of 183 ingredients contained in 199 products had evidence to support claims.
40
Total Studies
8.7/10
Avg Quality
10-4,631
Sample Size Range
2005-2025
Research Span

Study Type Distribution

RCT
16
Meta-Analysis
12
Systematic Review
11
In Vitro
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.